NCT04869761 - Stem Cell Therapy for Chronic Kidney Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

April 26, 2023

Study Completion Date

April 26, 2023

Conditions

Chronic Kidney DiseasesDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes MellitusDiabetic Nephropathies

Interventions

DRUG

Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion

Single MSC infusion of 150x10\^6 cells at time zero; intravenous delivery

DRUG

Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions

Two MSC infusions of 75x10\^6 cells at time zero and three months; intravenous delivery

Trial Locations (2)

Mayo Clinic Florida, Jacksonville

Mayo Clinic in Rochester, Rochester

All Listed Sponsors

lead

LaTonya J. Hickson

OTHER